Camilla J. Buckley

Oxford, ENG, United Kingdom

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 23 publications

Frequent co-occurrence of AChR-positive myasthenia gravis in facioscapulohumeral muscular dystrophy suggests a novel disease association.

Frequent co-occurrence of AChR-positive myasthenia gravis in facioscapulohumeral muscular dystrophy suggests a novel disease association.

Journal: Journal of neurology, neurosurgery, and psychiatry
Published: September 03, 2025

Two case reports of distal upper limb weakness following influenza-like illness: an emerging pattern of para-infectious myositis in adults.

Two case reports of distal upper limb weakness following influenza-like illness: an emerging pattern of para-infectious myositis in adults.

Journal: BMC neurology
Published: January 21, 2020

Paediatric myasthenia gravis: Prognostic factors for drug free remission.

Paediatric myasthenia gravis: Prognostic factors for drug free remission.

Journal: Neuromuscular disorders : NMD
Published: July 04, 2019

Minimal manifestation status and prednisone withdrawal in the MGTX trial.

Minimal manifestation status and prednisone withdrawal in the MGTX trial.

Journal: Neurology
Published: June 14, 2019

Intravenous immunoglobulin and rituximab versus placebo treatment of antibody-associated psychosis: study protocol of a randomised phase IIa double-blinded placebo-controlled trial (SINAPPS2).

Intravenous immunoglobulin and rituximab versus placebo treatment of antibody-associated psychosis: study protocol of a randomised phase IIa double-blinded placebo-controlled trial (SINAPPS2).

Journal: Trials
Published: January 07, 2019

Association of Leucine-Rich Glioma Inactivated Protein 1, Contactin-Associated Protein 2, and Contactin 2 Antibodies With Clinical Features and Patient-Reported Pain in Acquired Neuromyotonia.

Association of Leucine-Rich Glioma Inactivated Protein 1, Contactin-Associated Protein 2, and Contactin 2 Antibodies With Clinical Features and Patient-Reported Pain in Acquired Neuromyotonia.

Journal: JAMA neurology
Published: September 23, 2018

Disrupted AMPA Receptor Function upon Genetic- or Antibody-Mediated Loss of Autism-Associated CASPR2.

Disrupted AMPA Receptor Function upon Genetic- or Antibody-Mediated Loss of Autism-Associated CASPR2.

Journal: Cerebral cortex (New York, N.Y. : 1991)
Published: May 15, 2018

Long-term effect of thymectomy plus prednisone versus prednisone alone in patients with non-thymomatous myasthenia gravis: 2-year extension of the MGTX randomised trial.

Long-term effect of thymectomy plus prednisone versus prednisone alone in patients with non-thymomatous myasthenia gravis: 2-year extension of the MGTX randomised trial.

Journal: The Lancet. Neurology
Published: April 20, 2018

Ion channels in EEG: isolating channel dysfunction in NMDA receptor antibody encephalitis.

Ion channels in EEG: isolating channel dysfunction in NMDA receptor antibody encephalitis.

Journal: Brain : a journal of neurology
Published: October 05, 2017

Immune or Genetic-Mediated Disruption of CASPR2 Causes Pain Hypersensitivity Due to Enhanced Primary Afferent Excitability.

Immune or Genetic-Mediated Disruption of CASPR2 Causes Pain Hypersensitivity Due to Enhanced Primary Afferent Excitability.

Journal: Neuron
Published: August 08, 2017

Intracellular and non-neuronal targets of voltage-gated potassium channel complex antibodies.

Intracellular and non-neuronal targets of voltage-gated potassium channel complex antibodies.

Journal: Journal of neurology, neurosurgery, and psychiatry
Published: August 25, 2016

Randomized Trial of Thymectomy in Myasthenia Gravis.

Randomized Trial of Thymectomy in Myasthenia Gravis.

Journal: The New England journal of medicine
Published: August 11, 2016
Showing 1-12 of 23

Last Updated: 09/26/2026